Co-use of a clusterin inhibitor with an egfr inhibitor to treat cancer
GB Tremblay, E Viau, M Filion - US Patent 9,822,170, 2017 - Google Patents
Epidermal growth factor receptor (EGFR) expression and phosphorylation is increased in
cancer cells treated with anti-clusterin antibodies. Such treatment is also accompanied with …
cancer cells treated with anti-clusterin antibodies. Such treatment is also accompanied with …
Anti-galectin-9 antibody and methods of use thereof
LC Ndhlovu, T Niki - US Patent 11,912,772, 2024 - Google Patents
US11912772B2 - Anti-galectin-9 antibody and methods of use thereof - Google Patents
US11912772B2 - Anti-galectin-9 antibody and methods of use thereof - Google Patents Anti-galectin-9 …
US11912772B2 - Anti-galectin-9 antibody and methods of use thereof - Google Patents Anti-galectin-9 …
Anti-L1-CAM antibodies and uses thereof
NKV Cheung, H Xu, M Suzuki-nishijima… - US Patent …, 2023 - Google Patents
C07K16/2809—Immunoglobulins [IGs], eg monoclonal or polyclonal antibodies against
material from animals or humans against receptors, cell surface antigens or cell surface …
material from animals or humans against receptors, cell surface antigens or cell surface …
Anti-l1-cam antibodies and uses thereof
NK Cheung, H Xu, M SUZUKI-NISHIJIMA… - 2018 - Google Patents
C07K16/2809—Immunoglobulins [IGs], eg monoclonal or polyclonal antibodies against
material from animals or humans against receptors, cell surface antigens or cell surface …
material from animals or humans against receptors, cell surface antigens or cell surface …
Anti-clusterin antibodies and antigen binding fragments and their use to reduce tumor volume
GB Tremblay, M Filion, T Sulea - US Patent 9,512,211, 2016 - Google Patents
2005/0048490 A1 3, 2005 2005/O152903 A1 7/2005 2005/0208558 A1 9, 2005
2005/0222027 A1 10, 2005 2005/0255114 A1 11/2005 2006, OO29956 A1 2, 2006 2006 …
2005/0222027 A1 10, 2005 2005/0255114 A1 11/2005 2006, OO29956 A1 2, 2006 2006 …